berberine has been researched along with glucagon-like peptide 2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, BC; Chen, LM; Kong, Y; Ren, HZ; Shan, CY; Wang, XY; Wang, Y; Xu, YG; Yang, JH; Zheng, MY | 1 |
| Liu, XZ; Pan, W; Xu, JH; Zou, DJ | 1 |
| Jiang, Y; Kong, Y; Liu, H; Ren, H; Shan, C; Wang, J; Wang, S; Wang, Y; Yang, J; Yang, Y; Zheng, M | 1 |
3 other study(ies) available for berberine and glucagon-like peptide 2
| Article | Year |
|---|---|
Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats.
Topics: Animals; Berberine; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Glucagon-Like Peptide 2; Glucose; Humans; Intestinal Mucosa; Intestines; Male; Rats; Rats, Sprague-Dawley; Zonula Occludens-1 Protein | 2013 |
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels.
Topics: Animals; Berberine; Dietary Fats; Endotoxemia; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Male; Obesity; Peptide YY; Rats; Rats, Sprague-Dawley | 2017 |
Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.
Topics: Animals; Berberine; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Gastrointestinal Microbiome; Glucagon-Like Peptide 2; Intestinal Mucosa; Intestinal Secretions; Male; Obesity; Prediabetic State; Rats; Rats, Zucker | 2021 |